Home  |  Contact Us  |  Subscribe  | About Us

About Singulex
Board of Directors
Executive Management
Press Releases
Career Opportunities
Contact Us

Press Releases


Date   Headline (click for details)  
2013-Nov-19 Singulex’s Assay for Cardiovascular Risk Assessment Highlighted in Two Presentat...
2013-Nov-12 Singulex Announces Two Studies Utilizing Company’s Proprietary System for Cardio...
2013-Oct-29 Singulex Announces Key Additions to Executive Management Team
2013-Sep-26 Singulex Secures $55 Million in Debt and Equity Financing
2013-Jul-31 Singulex’s Erenna® Single Molecule Counting Technology an Enabling Factor in Two...
2013-May-23 Singulex Names Guido Baechler President and Chief Executive Officer
2013-Mar-07 New Data from TIMI Study Group to Be Presented at American College of Cardiology...
2012-May-01 Singulex Adds IL-17A/F to Suite of TH17 Pathway Immunoassay Kits
2012-Mar-22 High Sensitivity Cardiac Troponin-I Assay Could Identify Future Risk for Dying f...
2010-Dec-14 Singulex Announces Issuance of U.S. Patents for Single Molecule Detection of Pro...
2010-Sep-02 Singulex Launches Presence In Europe
2009-Jun-15 Frost & Sullivan Recognizes Singulex for Erenna® Immunoassay System
2009-Jan-12 Singulex Closes $19 Million Financing Round


For more information about our company, please contact us.